CompletedNot Applicable

Effectiveness of High-intensity Laser Therapy in De Quervain Tenosynovitis

Turkey (Türkiye)64 participantsStarted 2022-03-11

Plain-language summary

68 De Quervain tenosynovitis(MPS) diagnosed patients will be randomly divided into 2 groups. To groups; splinting+exercise+high-intensity laser therapy (HILT) and splinting+exercise+sham HILT will be applied. Visual anolog scale (VAS) scores, quick Disabilities of the Arm, Shoulder, and Hand (QDASH) questionnaire and Hand grip strength measurements of the patients before-after treatment will be recorded and will be evaluated statistically.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients diagnosed with unilateral De Quervain tenosynovitis 18-65 years old Exclusion Criteria: * pain history of less than four weeks, * upper extremity entrapment neuropathy, * major psychiatric disease, * upper extremity surgical treatment history, * malignancy history, * chronic rheumatic disease, * cervical radiculopathy, * cervical myelopathy, * local corticosteroid injection prior to De Quervain tenosynovitis and receiving physical therapy.

What they're measuring

quick Disabilities of the Arm, Shoulder, and Hand (QDASH) questionnaire

Timeframe: 5 Minutes

JAMAR hydraulic hand dynamometer

Timeframe: 2 minutes

Trial details

NCT IDNCT05141799

SponsorKocaeli University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-06-30

View on ClinicalTrials.gov More De Quervain Disease trials